GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atossa Therapeutics Inc (FRA:YAG2) » Definitions » Cyclically Adjusted FCF per Share

Atossa Therapeutics (FRA:YAG2) Cyclically Adjusted FCF per Share : €-32.83 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Atossa Therapeutics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Atossa Therapeutics's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.035. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-32.83 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Atossa Therapeutics was 13.80% per year. The lowest was 7.70% per year. And the median was 10.75% per year.

As of today (2024-05-20), Atossa Therapeutics's current stock price is €1.42. Atossa Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-32.83. Atossa Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Atossa Therapeutics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Atossa Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atossa Therapeutics Cyclically Adjusted FCF per Share Chart

Atossa Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.29 -41.60 -46.09 -44.15 -37.87

Atossa Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.31 -43.35 -37.95 -37.87 -32.83

Competitive Comparison of Atossa Therapeutics's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Atossa Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atossa Therapeutics's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atossa Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Atossa Therapeutics's Cyclically Adjusted Price-to-FCF falls into.



Atossa Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Atossa Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.035/131.7762*131.7762
=-0.035

Current CPI (Mar. 2024) = 131.7762.

Atossa Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -12.676 100.560 -16.611
201409 -17.537 100.428 -23.011
201412 -15.358 99.070 -20.428
201503 -20.268 99.621 -26.810
201506 -20.292 100.684 -26.558
201509 -20.435 100.392 -26.823
201512 -18.257 99.792 -24.108
201603 -13.538 100.470 -17.756
201606 -6.838 101.688 -8.861
201609 2.246 101.861 2.906
201612 -4.066 101.863 -5.260
201703 -66.923 102.862 -85.735
201706 -1.928 103.349 -2.458
201709 -1.381 104.136 -1.748
201712 -0.536 104.011 -0.679
201803 -8.946 105.290 -11.196
201806 -0.510 106.317 -0.632
201809 -0.380 106.507 -0.470
201812 -0.386 105.998 -0.480
201903 -0.290 107.251 -0.356
201906 -0.243 108.070 -0.296
201909 -0.176 108.329 -0.214
201912 -0.267 108.420 -0.325
202003 -0.320 108.902 -0.387
202006 -0.215 108.767 -0.260
202009 -0.224 109.815 -0.269
202012 -0.168 109.897 -0.201
202103 -0.040 111.754 -0.047
202106 -0.036 114.631 -0.041
202109 -0.021 115.734 -0.024
202112 -0.026 117.630 -0.029
202203 -0.035 121.301 -0.038
202206 -0.044 125.017 -0.046
202209 -0.043 125.227 -0.045
202212 -0.034 125.222 -0.036
202303 -0.052 127.348 -0.054
202306 -0.033 128.729 -0.034
202309 -0.029 129.860 -0.029
202312 -0.041 129.419 -0.042
202403 -0.035 131.776 -0.035

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Atossa Therapeutics  (FRA:YAG2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Atossa Therapeutics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Atossa Therapeutics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Atossa Therapeutics (FRA:YAG2) Business Description

Industry
Traded in Other Exchanges
Address
107 Spring Street, Seattle, WA, USA, 98104
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Atossa Therapeutics (FRA:YAG2) Headlines

No Headlines